SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | (FY)Jan 28, 2023 | (Q4)Jan 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -106.09%-2.54M | 186.76%18.52M | 6.31%-34.65M | 11.69%52.27M | 113.42%68.9M | 537.28%41.69M | -186.03%-21.34M | -119.59%-36.99M | 316.38%46.79M | -43.08%32.29M |
Net income from continuing operations | 72.65%-364K | -79.62%-5.91M | -15.52%-18.07M | -171.57%-29M | -179.24%-8.74M | -110.34%-1.33M | -122.50%-3.29M | -882.73%-15.64M | -62.65%40.52M | -81.13%11.03M |
Operating gains losses | --28K | --457K | --16K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -6.37%9.98M | 13.30%10.16M | 18.33%10.39M | 22.76%39.01M | 20.92%10.6M | 36.03%10.66M | 15.52%8.97M | 18.50%8.78M | 21.16%31.78M | 18.03%8.76M |
Deferred tax | 113.06%558K | -53.83%-2.07M | -420.67%-5.47M | -366.91%-10.05M | -164.46%-3.39M | -496.51%-4.27M | -166.47%-1.34M | -294.74%-1.05M | -29.56%3.77M | -11.05%5.25M |
Other non cash items | -46.27%6.4M | -97.78%202K | -187.81%-3.15M | -40.02%17.25M | -198.70%-7.35M | 130.04%11.92M | -27.37%9.11M | -0.33%3.59M | -9.50%28.77M | -28.32%7.45M |
Change In working capital | -185.04%-20.2M | 140.25%14.45M | 42.35%-19.55M | 149.14%30.81M | 5,766.03%76.89M | 220.46%23.75M | -235.92%-35.91M | -9.61%-33.91M | 68.14%-62.7M | 94.89%-1.36M |
-Change in receivables | 356.50%849K | 45.66%-194K | 104.96%18K | 42.24%-67K | 367.39%984K | -246.46%-331K | 45.66%-357K | -153.15%-363K | 91.45%-116K | 70.63%-368K |
-Change in inventory | -789.38%-74.7M | 128.79%28.21M | 47.51%-36.93M | 453.42%44.42M | 6.49%91.61M | 122.68%10.84M | 1,406.04%12.33M | -41.07%-70.36M | 91.22%-12.57M | 105.14%86.03M |
-Change in prepaid assets | 8.57%-2.78M | 141.83%2.16M | 6.74%839K | 4,650.00%2.09M | 398.52%9.5M | -285.63%-3.04M | -1,160.49%-5.15M | -22.49%786K | 99.35%-46K | 49.60%-3.18M |
-Change in payables and accrued expense | 283.64%64.7M | 61.46%-13.95M | -63.15%15.11M | 58.36%-6.69M | 61.17%-28.36M | -42.58%16.86M | -2,169.30%-36.19M | 58.66%41M | 31.06%-16.07M | -17.14%-73.03M |
-Change in other current liabilities | -49.05%-7.76M | 64.99%-1.68M | 373.52%1.48M | 67.90%-8.13M | 135.60%2.41M | -57.66%-5.21M | 21.28%-4.79M | 94.12%-540K | 4.32%-25.34M | -21.42%-6.76M |
-Change in other working capital | -110.83%-501K | 94.85%-90K | 98.69%-58K | 90.59%-806K | 118.46%748K | 3,403.03%4.62M | 66.67%-1.75M | -849.92%-4.43M | -286.95%-8.57M | -157.89%-4.05M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -106.09%-2.54M | 186.76%18.52M | 6.31%-34.65M | 11.69%52.27M | 113.42%68.9M | 537.28%41.69M | -186.03%-21.34M | -119.59%-36.99M | 316.38%46.79M | -43.08%32.29M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 81.15%-3.62M | 85.13%-4.34M | 85.55%-3.29M | -31.87%-79.9M | 60.54%-8.73M | -20.83%-19.2M | -175.94%-29.21M | -89.63%-22.76M | -13.35%-60.59M | -47.51%-22.11M |
Net PPE purchase and sale | 81.15%-3.62M | 85.13%-4.34M | 85.55%-3.29M | -31.87%-79.9M | 60.54%-8.73M | -20.83%-19.2M | -175.94%-29.21M | -89.63%-22.76M | -13.35%-60.59M | -47.51%-22.11M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 81.15%-3.62M | 85.13%-4.34M | 85.55%-3.29M | -31.87%-79.9M | 60.54%-8.73M | -20.83%-19.2M | -175.94%-29.21M | -89.63%-22.76M | -13.35%-60.59M | -47.51%-22.11M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 127.88%6.26M | -127.34%-13.78M | -38.79%36.97M | 169.50%28.38M | -479.53%-59.95M | -481.56%-22.47M | 176.48%50.41M | 104.51%60.39M | -161.34%-40.84M | -181.09%-10.35M |
Net issuance payments of debt | 129.38%6.58M | -124.95%-13M | -40.68%37.1M | 79.68%38.54M | -331.67%-53.73M | -236.52%-22.38M | 475.73%52.12M | 99.31%62.53M | -67.53%21.45M | -225.93%-12.45M |
Net common stock issuance | --0 | 113.03%208K | --0 | 95.76%-2.75M | 84.07%-456K | --0 | 96.90%-1.6M | ---696K | ---64.75M | ---2.86M |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | -10.96%796K | ---- | ---- | ---- | ---- | --894K | ---- |
Net other financing activities | -238.04%-311K | -782.14%-988K | 90.87%-132K | -622.74%-8.21M | -261.09%-6.56M | 38.26%-92K | 77.91%-112K | 21.68%-1.45M | 203.68%1.57M | 41.70%4.07M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 127.88%6.26M | -127.34%-13.78M | -38.79%36.97M | 169.50%28.38M | -479.53%-59.95M | -481.56%-22.47M | 176.48%50.41M | 104.51%60.39M | -161.34%-40.84M | -181.09%-10.35M |
Net cash flow | ||||||||||
Beginning cash position | -11.51%2.56M | -28.68%2.17M | 31.48%3.14M | -95.81%2.39M | 13.87%2.92M | -51.93%2.89M | -94.73%3.04M | -95.81%2.39M | -12.98%57.02M | 1.11%2.56M |
Current changes in cash | 381.82%106K | 366.67%392K | -249.46%-973K | 101.38%752K | 232.16%226K | 100.64%22K | 99.72%-147K | -5.24%651K | -542.17%-54.63M | -100.31%-171K |
End cash Position | -8.54%2.67M | -11.51%2.56M | -28.68%2.17M | 31.48%3.14M | 31.48%3.14M | 13.87%2.92M | -51.93%2.89M | -94.73%3.04M | -95.81%2.39M | -95.81%2.39M |
Free cash flow | -127.38%-6.16M | 127.98%14.14M | 36.46%-37.96M | -65.27%-27.63M | 729.93%60.18M | 340.63%22.49M | -455.46%-50.56M | -107.12%-59.74M | 77.73%-16.72M | -82.62%7.25M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |